Jobs / United States / Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

Scientist II, Validation

Seattle Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordUSCIS Data Hub records 3 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
USCIS Data Hub records 3 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it. Source: US Department of Labor visa filings (LCA) (US Department of Labor (OFLC), plus USCIS H-1B Employer Data Hub).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

At Adaptive, we’re Powering the Age of Immune Medicine. Our goal is to harness the power of the adaptive immune system to transform the way diseases are diagnosed and treated. As an Adapter, you’ll have the opportunity to make a difference in people’s lives. With Adaptive, you’ll create a career highlight through collaboration with bright, curious colleagues working at the apex of innovation and application. It’s time for your next chapter. Discover your story with Adaptive. Position Overview Adaptive is seeking a motivated and high-performing Scientist II to support late-stage development activities for regulated NGS-based immunosequencing products as part of the Clinical Product Development organization. This role spans activities from late development, validation, and launch of new product applications within Adaptive’s Diagnostics business. The Scientist II will participate on cross-functional teams implementing assays in Adaptive’s CLIA-certified and CAP-accredited production laboratory and will contribute to the creation of design history files and the design and execution of validation studies. The candidate will also interface with the medical team to provide requirements and recommendations for clinical trials to obtain samples for development and validation of new disease assays. Key Responsibilities and Essential Functions • Responsible for development and validation of regulated assays within a matrixed core-team environment for Adaptive’s Diagnostics business. Focus will be supporting validation activities related to new indications for clonoSEQ single-site IVD and laboratory developed test (LDTs) products. Additionally, this role may support development and validation of GCP-compliant investigational use assays that serve as precursors to future clinical assays and drive pharma partnerships using assay results endpoints in drug trials. • Independently manage IVD-level verification and validation studies (AV/CV), providing innovative strategies to comply with appropriate regulatory guidance and standards, including FDA, ISO, and CLSI. Must deliver results according to study timelines, product development plans, design trace matrices, and other Design Control related requirements. • Establish sample processing plans, execute applicable sample manipulation and contriving, and coordinate validation study execution with Adaptive’s clinical lab. • Author technical documents (protocols/reports), contribute to document review, and compile/reference supplementary documents for data packages/submissions. • Participate in cross-functional core teams with the R&D, Biostatistics, Computational Biology, Clinical Lab Operations, RA/QA, Commercial, and Business Development groups to ensure project/product success. Engage deeply to understand requirements from different functional areas, propose solutions, and facilitate issue resolution. • Become a subject matter expert on Adaptive’s products. Provide scientific guidance and technical expertise. • Ensure compliance with internal procedures, design control, FDA and CLSI guidelines and other applicable standards and regulations. Performs activities covered by GMP regulations. • All other duties as assigned. Position Requirements (Education, Experience, Other) Required • PhD in Molecular Biology, Biomedical Engineering, or related field with 2+ years’ experience in relevant industry setting; or MS degree with 10+ years’ experience in relevant industry setting • Solid understanding of multiplex PCR and NGS technologies • Experience designing and executing formal verification and validation studies • Exceptional scientific technical writing, communication, and organizational skills, with significant attention to detail. Must be able to communicate effectively, both wri

Apply on employer site ↗